|
PRESS
PRESS RELEASE
Madison, WI -- August 10, 2007
- Scientific Commercialization LLC is pleased to announce the addition of a new Principal to the firm. Tom Gay has recently joined the firm, bringing with him 24 years of pharmaceutical industry experience.
"We are delighted to have Tom as an addition to our highly respected staff, he represents a strengthening of our capabilities within late stage development through the commercialization process and life cycle management" says Daniel Leonard, Managing Partner of Scientific Commercialization LLC.
About Tom Gay - Tom is a successful senior level executive with 24 years of experience in the healthcare industry, with a strong record of leading in a matrix environment, building business capabilities, change management and team development. He holds a bachelors degree in Biology from the University of Scranton, a Masters Degree in Pharmaceutical Regulatory Affairs from Temple University and a Certificate from The Wharton School's Executive Development Program.
August 24, 2006 - New Sage Inc.
PRESS RELEASE
Madison, WI -- August 24, 2006 - Scientific Commercialization LLC and New Sage Inc. today announced plans to join forces. The combination will create a Management Consulting powerhouse by bringing Scientific Commercialization's leadership in Business Strategy Planning, Execution and Evaluation together with New Sage's strengths in e-Learning, Technology Platform Development and Delivery. The result: A new and more formidable company, determined to drive growth, innovation and choice for its customers, particularly in the Strategic Intelligence, Medical Affairs, Sales and Marketing and Regulatory segments as well as in the rapidly-growing e-Learning market. Combining people, processes, technologies and complementary strengths, Scientific Commercialization plans to deliver in 2007 customer-centric offerings for the benefit of customers who want to collaborate in the development of differentiated solutions.
Scientific Commercialization's acquisition of New Sage Inc. will position the new company to deliver innovations that fulfill the increasing demand for more integrated solutions in key market segments while also continuing to develop "best-of-breed" e-Learning products that empower customers to choose the combination of technologies that best serves their needs. In 2008 and beyond, Scientific Commercialization aims to support our customers' success and to address the growing need for increased performance from existing assets. Thus, the combined company intends to both partner with its customers to create unique solutions within an open-innovation ecosystem free from artificial barriers to customer success and offer standard solutions for common unmet business needs.
"New Sage Inc. shares our passion and complements our strengths: market leadership and customer centric innovation," said Scientific Commercialization Managing Partner Daniel Leonard. "Bringing these two great companies together will allow us to transcend what we have accomplished as individual businesses and reinvent our market position as the partner of choice. We believe Scientific Commercialization and New Sage Inc. will drive growth and innovation for the entire Healthcare and e-Learning industries, enabling our customers to create differentiated solutions and supporting their success. "
"This combination means accelerated growth for New Sage, and broader horizons for our offerings," said Nathan Pienkowski, President and CEO of New Sage. "All of our offerings will benefit. Joining with Scientific Commercialization will enable us to innovate aggressively on the New Sage platform, and continue to invest significantly in our business to stay in front of our markets."
About Scientific Commercialization
Scientific Commercialization provides innovative consulting that enables our customers to maximize their commercial success. Through an integrative approach that leverages a combination of deep expertise in the healthcare industry, scientific knowledge, and commercial insight across the value chain, and a methodological framework that ensures optimal human performance, Scientific Commercialization provides its customers with innovative solutions for successful Scientific and Commercial Life Cycle Management.
About New Sage Inc.
New Sage Learning Systems creates online learning experiences custom designed to educate client employees, partners, and customers. New Sage has created over 100 hours of online training and earned the confidence of clients like the American College of Surgeons, the Bill and Melinda Gates Foundation, Blue Cross & Blue Shield, IBM, Johnson & Johnson, and Wyeth.
New Sage's strength lies in the ability to create truly effective learning experiences. Courses are designed by experts with advanced degrees in the learning sciences and experience solving challenging human performance problems. In addition, New Sage is pioneering an innovative approach to online instruction, called Situated Learning. Based on over 30 years of educational research at Northwestern, Stanford, Vanderbilt, and Yale, Situated Learning is designed to accomplish the holy grail of instruction: helping people to transfer skills from the learning environment to the work environment.
PharmaVOICE December 2003 (PDF Document)
Dr. Bill Massey, partner at Scientific Commercialization, is interviewed with other industry leaders. The topic is Phase IV trials.
To request a printed copy of this article, please email us at success@scientificcommercialization.com or call 608.827.3000.
|